Solid Tumour Clinical Trials
23 clinical trials for Solid Tumour across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol — RECRUITING · PHASE2
- DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations — RECRUITING · PHASE2
- DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations — RECRUITING · PHASE2
- DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers — RECRUITING · PHASE2
- DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. — RECRUITING · PHASE2
- DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. — RECRUITING · PHASE2
- A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. — RECRUITING · PHASE1
- ADC-induced Neurotoxicity Treated With Duloxetine — RECRUITING · PHASE2
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. — NOT_YET_RECRUITING · PHASE2
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors — TERMINATED · PHASE1
- Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors — COMPLETED · PHASE1
- A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours — COMPLETED · PHASE1
- CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia — WITHDRAWN · PHASE1
- A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole — COMPLETED · PHASE1
- An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers — COMPLETED · PHASE1
- Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor — COMPLETED · PHASE1
- Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors — TERMINATED · PHASE1
- A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours — COMPLETED · PHASE1
- Nivestim™ in Treatment of Malignant Diseases — COMPLETED
- A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. — TERMINATED · PHASE1
- Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile — OTHER · PHASE1
- Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer — OTHER · PHASE2
- Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors — COMPLETED · PHASE1
Refine this search